Clinical Trial Update: A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TAK-954 in adults with postoperative gastrointestinal dysfunction has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Gastrointestinal Dysfunction

Drugs mentioned

• TAK-954

Snippet

Sponsor: Takeda | Conditions: Postoperative Gastrointestinal Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2023-06-23